Cardiovasc Diabetol 17:153 Chilton R, Tikkanen I, Cannon CP et al (2015) Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
Traditional strategies encompass karyotyping, hormonal support, anticoagulation for thrombophilia, and immunological workup
But some might say, well, that inference is reasonable, but that doesnt prove it because that could be a peripheral effect that is then just then communicating to the brain
Data revealed tirzepatides protective effects are mediated through activation of the PI3K/Akt signalling pathway, known to be responsible for cell survival and metabolism
Tirzepatide is a dual GIP/GLP-1 receptor agonist administered as weekly subcutaneous injections, starting at 2.5mg and titrating up to 15mg based on tolerance and weight loss response
Pharmaceuticals 13 , 38 (2020)